Quoin Pharmaceuticals, Ltd. (NasdaqCM:QNRX) is looking for M&A opportunities. Dr. Michael Myers, Chief Executive Officer said, "we believe that in addition to enable us to advance the clinical development of our product pipeline, this strong cash position will also support our plans to pursue attractive M&A opportunities in the rare and orphan disease space. We are particularly interested in acquiring derisk late-stage assets.

And while there can be no assurances of the deal being executed, I can tell you that we are actively exploring a number of potentially interesting opportunities".